                         SEQUENCE LISTING

<110>  The Regents of the University of California
       Witztum, Joseph
       Tsimikas, Sotirios
 
<120>  OXIDATIVE BIOMARKERS IN PREDICTING RISK OF STROKE, TRANSIENT 
       ISCHEMIC ATTACK (TIA) and PERIPHERAL ARTERIAL DISEASE (PAD)

<130>  00015-223WO1

<140>  Not yet assigned
<141>  2013-07-24

<150>  US 61/675,164
<151>  2012-07-24

<160>  35    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus mimotope sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is N, E, Q, A, H, T, G or D

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is S, N, V, R, A, W, Y or D

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is W, R, Y, M, I, L, V, G, T or P

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is T, N, S or F

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is N, K or S

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is A, N, S, D, W, L, Y, T, I, V, K or P

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is S, W, D, T, A, Q, M, E or P

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is L, Q, A, V, G, M, H, S, E or N

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is S, W, H, M, L, A, E, T, D, Q, or R

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is T, Y, R, S, Q, L, F, V, A, D or I

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is F, I, H, L, M, V, or P

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is H, Q, G, S, M, A, P, W or L

<400>  1

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus cyclic mimotope sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is N, K, Q or D

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is N or W

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is W, R, Y, Q, S or A

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is N, K, H or P

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is M, Q or H

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is P, R or F

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is L or T

<400>  2

Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5           


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  3

Asn Ser Trp Thr Asn Ala Ser Leu Ser Thr Phe His 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  4

Asn Ser Arg Thr Asn Asn Ser Gln Trp Thr Phe Gln 
1               5                   10          


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  5

Glu Ser Trp Thr Asn Ser Trp Ala His Tyr Phe Gly 
1               5                   10          


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  6

Glu Ser Trp Thr Asn Ser Trp Ala Met Tyr Phe Gly 
1               5                   10          


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  7

Gln Ser Tyr Thr Asn Asp Asp Val Leu Arg Ile Ser 
1               5                   10          


<210>  8
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  8

Gln Asn Met Asn Asn Trp Thr Leu Ala Ser Ile Met 
1               5                   10          


<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  9

Glu Val Met Asn Asn Trp Thr Leu Ala Ser Ile Met 
1               5                   10          


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  10

Ala Ser Ile Ser Asn Leu Thr Leu Ser Arg Phe Met 
1               5                   10          


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  11

His Ser Trp Ser Asn Tyr Trp Gly His Gln His Ala 
1               5                   10          


<210>  12
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  12

His Arg Ile Ser Asn Tyr Ala Met Glu Leu His Ser 
1               5                   10          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  13

His Ser Leu Thr Asn Thr Gln Met Thr Gln Leu Ser 
1               5                   10          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  14

His Ser Leu Ser Asn Ile Gln Met Ala Thr Leu Ala 
1               5                   10          


<210>  15
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  15

His Arg Met Thr Asn Ala Met His His Phe Met Gly 
1               5                   10          


<210>  16
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  16

His Arg Met Thr Asn Asn Ala Met Asp Val Phe Met 
1               5                   10          


<210>  17
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  17

His Arg Leu Thr Asn Ser Glu Gln Ala Ala Leu Pro 
1               5                   10          


<210>  18
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  18

Thr Ala Val Thr Asn Ser Met Met Glu Arg Leu Trp 
1               5                   10          


<210>  19
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  19

Gly Trp Gly Asn Lys Thr Pro Ser Gln Asp Val His 
1               5                   10          


<210>  20
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  20

Asp Tyr Thr Asn Ser Val Ser Met Arg Tyr Leu Ser 
1               5                   10          


<210>  21
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  21

His Gln Leu Ser Asn Lys Asp Glu Gln Thr Pro Gln 
1               5                   10          


<210>  22
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  22

Ala Asp Pro Phe Ser Pro Thr Asn Arg Ile Pro Leu 
1               5                   10          


<210>  23
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P1 mimotope

<400>  23

His Ser Trp Thr Asn Ser Trp Met Ala Thr Phe Leu 
1               5                   10          


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  24

Asn Asn Trp Asn Met Pro Leu 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  25

Asn Asn Arg Asn Met Pro Leu 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  26

Asn Asn Tyr Asn Met Pro Leu 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  27

Asn Asn Gln Asn Met Pro Leu 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  28

Asn Asn Trp Lys Met Pro Leu 
1               5           


<210>  29
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  29

Asn Asn Ser His Met Pro Leu 
1               5           


<210>  30
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope


<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  30

Lys Asn Ser Xaa Gln Pro Leu 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope


<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  31

Asn Asn Ser Xaa Met Pro Leu 
1               5           


<210>  32
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  32

Gln Asn Ser His Met Pro Leu 
1               5           


<210>  33
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  33

Asn Asn Ser Lys Met Arg Leu 
1               5           


<210>  34
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide mimotope

<400>  34

Asp Trp Ala Pro His Phe Thr 
1               5           


<210>  35
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P2 mimotope

<400>  35

Asn Asn Ser Asn Met Pro Leu 
1               5           


